Cargando…

Pilot study evaluating the monitoring of canine diabetes mellitus in primary care practice

OBJECTIVES: This study aimed to describe how canine diabetes mellitus (CDM) is monitored in primary care practice (PCP) and to report outcomes. DESIGN: Retrospective case review. SETTING: PCP. PARTICIPANTS: 40 dogs of 22 different pedigrees and five crossbreeds. Median age at diagnosis was nine year...

Descripción completa

Detalles Bibliográficos
Autores principales: Cartwright, Jennifer Ann, Cobb, Malcolm, Dunning, Mark D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6541103/
https://www.ncbi.nlm.nih.gov/pubmed/31205722
http://dx.doi.org/10.1136/vetreco-2017-000250
_version_ 1783422718315593728
author Cartwright, Jennifer Ann
Cobb, Malcolm
Dunning, Mark D
author_facet Cartwright, Jennifer Ann
Cobb, Malcolm
Dunning, Mark D
author_sort Cartwright, Jennifer Ann
collection PubMed
description OBJECTIVES: This study aimed to describe how canine diabetes mellitus (CDM) is monitored in primary care practice (PCP) and to report outcomes. DESIGN: Retrospective case review. SETTING: PCP. PARTICIPANTS: 40 dogs of 22 different pedigrees and five crossbreeds. Median age at diagnosis was nine years and six months (eight years six months to 10 years five months). Dogs were diagnosed with CDM between January 1, 2008 and December 30, 2012 and remained with the practice to the study end or until death. PRIMARY AND SECONDARY OUTCOME MEASURES: Stability achievement and death or euthanasia. Consultations for each dog were identified and recorded through records collected from the PCP (January 1, 2008 to December 30, 2012). RESULTS: A median of three consultations per dog occurred in the first month, subsequently falling to a median of one consultation every 19 days thereafter. After the first month postdiagnosis, weight and single blood glucose concentrations were most frequently recorded at 66.8 and 42 per cent of consultations respectively and a blood glucose curve was performed infrequently (17.4 per cent). Serum biochemistry was measured at 8 per cent of consultations and urine culture at only 0.8 per cent. Median survival time (MST) for all dogs was eight months (2–21 months). Eighteen dogs stabilised within three months of diagnosis and their MST was 20.5 months, (10.25–25.75 months), significantly longer than the 22 dogs not achieving stability within three months (MST 2.5 months, 0–5.5 months) (P<0.001). Those dogs not surviving beyond the first month had significantly fewer consultations than those still alive (P<0.005). CONCLUSIONS: This pilot study indicates dogs with CDM managed solely in PCP experience limited monitoring tests and have lower MST than reported in the literature. Recruitment of a larger cohort of CDM cases from a larger number of PCP will help determine whether these results accurately represent this demographic and verify if infrequent testing is associated with a poor outcome. Importantly, prospective evaluation of decision-making around monitoring CDM in PCP is required, to help determine the effectiveness and feasibility of more frequent monitoring strategies, such as those recommended by the American Animal Hospital Association, particularly to influence MST.
format Online
Article
Text
id pubmed-6541103
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-65411032019-06-14 Pilot study evaluating the monitoring of canine diabetes mellitus in primary care practice Cartwright, Jennifer Ann Cobb, Malcolm Dunning, Mark D Vet Rec Open Companion or Pet Animals OBJECTIVES: This study aimed to describe how canine diabetes mellitus (CDM) is monitored in primary care practice (PCP) and to report outcomes. DESIGN: Retrospective case review. SETTING: PCP. PARTICIPANTS: 40 dogs of 22 different pedigrees and five crossbreeds. Median age at diagnosis was nine years and six months (eight years six months to 10 years five months). Dogs were diagnosed with CDM between January 1, 2008 and December 30, 2012 and remained with the practice to the study end or until death. PRIMARY AND SECONDARY OUTCOME MEASURES: Stability achievement and death or euthanasia. Consultations for each dog were identified and recorded through records collected from the PCP (January 1, 2008 to December 30, 2012). RESULTS: A median of three consultations per dog occurred in the first month, subsequently falling to a median of one consultation every 19 days thereafter. After the first month postdiagnosis, weight and single blood glucose concentrations were most frequently recorded at 66.8 and 42 per cent of consultations respectively and a blood glucose curve was performed infrequently (17.4 per cent). Serum biochemistry was measured at 8 per cent of consultations and urine culture at only 0.8 per cent. Median survival time (MST) for all dogs was eight months (2–21 months). Eighteen dogs stabilised within three months of diagnosis and their MST was 20.5 months, (10.25–25.75 months), significantly longer than the 22 dogs not achieving stability within three months (MST 2.5 months, 0–5.5 months) (P<0.001). Those dogs not surviving beyond the first month had significantly fewer consultations than those still alive (P<0.005). CONCLUSIONS: This pilot study indicates dogs with CDM managed solely in PCP experience limited monitoring tests and have lower MST than reported in the literature. Recruitment of a larger cohort of CDM cases from a larger number of PCP will help determine whether these results accurately represent this demographic and verify if infrequent testing is associated with a poor outcome. Importantly, prospective evaluation of decision-making around monitoring CDM in PCP is required, to help determine the effectiveness and feasibility of more frequent monitoring strategies, such as those recommended by the American Animal Hospital Association, particularly to influence MST. BMJ Publishing Group 2019-05-24 /pmc/articles/PMC6541103/ /pubmed/31205722 http://dx.doi.org/10.1136/vetreco-2017-000250 Text en © British Veterinary Association 2019. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Companion or Pet Animals
Cartwright, Jennifer Ann
Cobb, Malcolm
Dunning, Mark D
Pilot study evaluating the monitoring of canine diabetes mellitus in primary care practice
title Pilot study evaluating the monitoring of canine diabetes mellitus in primary care practice
title_full Pilot study evaluating the monitoring of canine diabetes mellitus in primary care practice
title_fullStr Pilot study evaluating the monitoring of canine diabetes mellitus in primary care practice
title_full_unstemmed Pilot study evaluating the monitoring of canine diabetes mellitus in primary care practice
title_short Pilot study evaluating the monitoring of canine diabetes mellitus in primary care practice
title_sort pilot study evaluating the monitoring of canine diabetes mellitus in primary care practice
topic Companion or Pet Animals
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6541103/
https://www.ncbi.nlm.nih.gov/pubmed/31205722
http://dx.doi.org/10.1136/vetreco-2017-000250
work_keys_str_mv AT cartwrightjenniferann pilotstudyevaluatingthemonitoringofcaninediabetesmellitusinprimarycarepractice
AT cobbmalcolm pilotstudyevaluatingthemonitoringofcaninediabetesmellitusinprimarycarepractice
AT dunningmarkd pilotstudyevaluatingthemonitoringofcaninediabetesmellitusinprimarycarepractice